S. Vincent Rajkumar, M.D., has received the 2018 Distinguished Mayo Clinic Investigator Award. The Distinguished Mayo Clinic Investigator Award is presented to individuals whose research careers demonstrate evidence of great distinction, high distinguished scholarship, creative achievement, and excellence in education and administrative responsibilities.
Newly-discovered BRCA1 mutations known as “variant of unknown significance,” or VUS, could be harmful, making a woman’s risk of developing breast cancer as high as 72 percent. Fergus Couch, Ph.D., Chair of the Division of Experimental Pathology and Laboratory Medicine, discusses the issue.
At Mayo Clinic, we offer a comprehensive approach to testing that focuses on the best outcomes for the patient. Our testing method combines molecular and cytogenetic analysis (in addition to a standard morphological and histological assessment) to provide a clear picture of the diagnosis, prognosis, and treatment options. This approach maximizes the amount of information available, allowing for a tailored treatment plan.
Kevin C. Halling, M.D., Ph.D., a consultant in Mayo Clinic's Division of Laboratory Genetics and Genomics, spoke at the Individualizing Medicine Conference: Advancing Care through Genomics, on RNA sequencing.